1) DASH score
DASH上肢功能调查表
1.
How to choice an appropriate,reliable, responsive and easy outcome assessment? This study evaluates 10 patients with distal radius fracture using DASH score(disability of shoulder,arm and hand questionnaire), the PRWE score(patient-rated wrist evaluation questionnaire),the Levine\'s carpal tunnel questionnaire and the Gartland and Werley score,and objective analyses of their features.
但如何在众多的评价标准中选择一个合适的,可信的,敏感的而又简单的评价标准呢?本研究使用DASH上肢功能调查表、Levine腕管综合症问卷、Gartland和Werley腕关节评分以及PRWE评分分别对10名桡骨远端骨折患者进行预后评价,分析各种评价标准的特点。
2) upper limb function
上肢功能
1.
Effect of hemiplegic shoulder pain on recovery of upper limb function;
偏瘫肩痛对上肢功能恢复的影响
2.
Objective:To study the effect of intensive training on recovery of upper limb function in hemiplegic patients after stroke.
结果:经4个疗程治疗后,2组上肢功能评分及简易手功能检查评分与治疗前比较有一定程度的提高,且治疗组评分明显高于对照组(P<0。
3.
Objective:To observe the effect of CIMT on hemiplegic children s upper limb function in home rehabilitation.
目的:观察家庭康复中运用强制性诱导运动疗法(CIMT)对偏瘫患儿上肢功能的影响。
3) upper extremity function
上肢功能
1.
Effect of electromygraphic biofeedback on upper extremity function in patients with hemiplegia after stroke;
肌电生物反馈治疗对脑卒中偏瘫患者上肢功能的影响
2.
Long-term effects of community-based rehabilitation on upper extremity function and activities of daily living in stroke patients
社区康复对脑卒中患者上肢功能及日常生活活动能力的远期疗效观察
3.
Objective To investigate the effect of EMG-electrical stimulation on upper extremity function in patients with hemiplegia after stroke.
目的探讨肌电触发电刺激对脑卒中偏瘫患者上肢功能的影响。
4) upper and lower limb function
上下肢功能
1.
Objective: To study effect of hemiplegic shoulder pain and genu recurvatum on recovery of upper and lower limb function and research Preventive and therapeutic effect of early rehabilitation on them.
两组均常规进行神经内科药物治疗，康复组加以运动疗法等综合康复治疗，并对每组患者在入组时和6个月后利用Fugl-Meyer评定量表和神经功能缺损量表进行功能评定上下肢功能评定并进行肩痛、膝过伸的评定。
6) movement function
上肢运动功能
1.
Effect of head acupuncture combined with rehabilitation techniques on movement function of upper limbs after stroke;
头针结合康复技术对脑卒中患者上肢运动功能的影响
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条